Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis

Sameer A. Parikh, Hagop M. Kantarjian, Mary Ann Richie, Jorge E. Cortes, Srdan Verstovsek

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis'. Together they form a unique fingerprint.

Medicine & Life Sciences